Spots Global Cancer Trial Database for stage iii renal cell cancer

Every month we try and update this database with for stage iii renal cell cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery	NCT01061411	Clear Cell Sarc... Recurrent Renal... Stage III Renal... Stage IV Renal ...	Dalteparin Pharmacological... Sunitinib Malat...	18 Years -	Roswell Park Cancer Institute
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer	NCT00899860	Kidney Cancer		- 120 Years	Wake Forest University Health Sciences
Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer	NCT00541008	Kidney Cancer	sunitinib malat...	18 Years - 120 Years	UNICANCER
Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer	NCT00087022	Kidney Cancer	girentuximab placebo	18 Years - 120 Years	Heidelberg Pharma AG
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer	NCT00492440	Kidney Cancer Melanoma (Skin)	recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological...	18 Years -	Cytheris SA
Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer	NCT00087022	Kidney Cancer	girentuximab placebo	18 Years - 120 Years	Heidelberg Pharma AG
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate	NCT01582009	Clear Cell Rena... Recurrent Renal... Stage III Renal... Stage IV Renal ...	panobinostat everolimus laboratory biom... pharmacological... liquid chromato... mass spectromet... enzyme-linked i... immunohistochem...	18 Years -	Roswell Park Cancer Institute
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery	NCT00003604	Kidney Cancer	aldesleukin	-	National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Kidney Cancer	NCT00096629	Kidney Cancer	human prostate-... mouse prostate-...	18 Years -	Memorial Sloan Kettering Cancer Center
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer	NCT00053807	Kidney Cancer	aldesleukin recombinant int... fluorouracil adjuvant therap...	- 75 Years	European Organisation for Research and Treatment of Cancer - EORTC
Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer	NCT00727532	Hereditary Clea... Kidney Cancer	Sorafenib	18 Years - 120 Years	Northwestern University
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer	NCT00002475	Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc...	allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid...	18 Years -	National Cancer Institute (NCI)
DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE	NCT00900536	Kidney Cancer	mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Metastatic Kidney Cancer	NCT00024388	Kidney Cancer	DHA-paclitaxel	18 Years -	National Cancer Institute (NCI)
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies	NCT01243359	Clear Cell Rena... Recurrent Renal... Stage I Renal C... Stage II Renal ... Stage III Renal... Stage IV Renal ... Unspecified Adu...	sunitinib malat... bevacizumab pharmacological... laboratory biom... fluorine F 18 f... positron emissi... computed tomogr...	18 Years -	National Cancer Institute (NCI)
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer	NCT00492440	Kidney Cancer Melanoma (Skin)	recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological...	18 Years -	Cytheris SA
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors	NCT00089362	Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas...	alvespimycin hy... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer	NCT00016939	Kidney Cancer	alvocidib	-	National Cancer Institute (NCI)
Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer	NCT00849186	Kidney Cancer	sunitinib malat... neoadjuvant the... therapeutic con...	18 Years -	Roswell Park Cancer Institute
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors	NCT03682289	Clear Cell Rena... Locally Advance... Locally Advance... Metastatic Mali... Metastatic Rena... Metastatic Urot... Metastatic Panc... Stage III Pancr... Stage III Renal... Stage IV Pancre... Stage IV Renal ... Endometrial Can... Metastatic Cast...	Ceralasertib Olaparib Durvalumab	18 Years -	University of California, San Francisco
Chemotherapy in Treating Patients With Advanced Kidney Cancer	NCT00011973	Kidney Cancer	fenretinide	18 Years -	Barbara Ann Karmanos Cancer Institute
Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer	NCT00016939	Kidney Cancer	alvocidib	-	National Cancer Institute (NCI)
Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery	NCT01688973	Recurrent Renal... Stage III Renal... Stage IV Renal ... Type 1 Papillar... Type 2 Papillar...	Erlotinib Hydro... Laboratory Biom... Tivantinib	-	National Cancer Institute (NCI)
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer	NCT03260504	Advanced Clear ... Stage III Renal... Stage IV Renal ... Metastatic Clea...	Aldesleukin Pembrolizumab	18 Years -	University of Washington
Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer	NCT00005045	Kidney Cancer	carboxyamidotri...	18 Years -	National Cancer Institute (NCI)
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer	NCT00436410	Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma	colloidal gold-... electron micros... pharmacological... conventional su...	18 Years -	National Institutes of Health Clinical Center (CC)
DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE	NCT00900536	Kidney Cancer	mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer	NCT00541008	Kidney Cancer	sunitinib malat...	18 Years - 120 Years	UNICANCER
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Vaccine Therapy in Treating Patients With Kidney Cancer	NCT00096629	Kidney Cancer	human prostate-... mouse prostate-...	18 Years -	Memorial Sloan Kettering Cancer Center
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer	NCT00589550	Kidney Cancer	PEG-interferon ... Sorafenib gene expression... polymerase chai... reverse transcr... flow cytometry immunoenzyme te... laboratory biom...	18 Years -	Ohio State University Comprehensive Cancer Center
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer	NCT00005027	Kidney Cancer	becatecarin	18 Years -	Barbara Ann Karmanos Cancer Institute
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer	NCT01727076	Head and Neck S... Recurrent Head ... Recurrent Non-S... Recurrent Renal... Recurrent Skin ... Stage III Renal... Stage IIIA Cuta... Stage IIIA Non-... Stage IIIB Cuta... Stage IIIB Non-... Stage IIIC Cuta... Stage IV Cutane... Stage IV Non-Sm... Stage IV Renal ...	Laboratory Biom... Pharmacological... Recombinant Hum...	19 Years -	National Cancer Institute (NCI)
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer	NCT02273752	Estrogen Recept... Gastrinoma Glucagonoma HER2-negative B... Insulinoma Mucositis Oral Complicati... Pancreatic Poly... Progesterone Re... Recurrent Breas... Recurrent Islet... Recurrent Renal... Somatostatinoma Stage III Renal... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Renal ...	Everolimus	18 Years -	Emory University
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer	NCT00006022	Kidney Cancer Melanoma (Skin)	aldesleukin bryostatin 1	18 Years - 120 Years	Virginia Commonwealth University
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer	NCT02664883	Healthy Subject Metastatic Rena... Recurrent Renal... Stage I Renal C... Stage II Renal ... Stage III Renal...	Computed Tomogr... Cytology Specim... Laboratory Biom... Magnetic Resona...	25 Years -	University of Southern California
Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer	NCT00331409	Kidney Cancer	Everolimus imatinib mesyla...	18 Years - 100 Years	OHSU Knight Cancer Institute
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer	NCT01026337	Renal Cell Carc... Stage III Renal... Stage IV Renal ...	mutation analys... pharmacological... dynamic contras... sunitinib malat... immunohistochem... laboratory biom...	18 Years -	Abramson Cancer Center at Penn Medicine
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer	NCT00589550	Kidney Cancer	PEG-interferon ... Sorafenib gene expression... polymerase chai... reverse transcr... flow cytometry immunoenzyme te... laboratory biom...	18 Years -	Ohio State University Comprehensive Cancer Center
Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer	NCT00849186	Kidney Cancer	sunitinib malat... neoadjuvant the... therapeutic con...	18 Years -	Roswell Park Cancer Institute
Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer	NCT00324740	Recurrent Renal... Stage III Renal... Stage IV Renal ...	vorinostat isotretinoin	21 Years -	National Cancer Institute (NCI)
Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer	NCT00077129	Kidney Cancer	carboplatin paclitaxel	18 Years - 120 Years	Eastern Cooperative Oncology Group
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer	NCT00908739	Kidney Cancer	gene expression... immunohistochem... laboratory biom...	-	Case Comprehensive Cancer Center
Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer	NCT00405366	Kidney Cancer	sorafenib tosyl...	18 Years -	UNC Lineberger Comprehensive Cancer Center
Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer	NCT00032188	Recurrent Renal... Stage III Renal... Stage IV Renal ...	aldesleukin bryostatin 1 laboratory biom...	18 Years -	National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer	NCT00016939	Kidney Cancer	alvocidib	-	National Cancer Institute (NCI)
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer	NCT02767921	Infiltrating Bl... Recurrent Bladd... Stage I Prostat... Stage I Renal C... Stage II Bladde... Stage II Renal ... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage III Renal...	Cytology Specim... Laboratory Biom... Radical Cystect... Recombinant Eph... Therapeutic Con...	18 Years -	University of Southern California
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer	NCT03260504	Advanced Clear ... Stage III Renal... Stage IV Renal ... Metastatic Clea...	Aldesleukin Pembrolizumab	18 Years -	University of Washington
Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer	NCT00496756	Kidney Cancer	Sorafenib	18 Years - 120 Years	University of Nebraska
Bryostatin 1 In Treating Patients With Progressive Kidney Cancer	NCT00005056	Kidney Cancer	bryostatin 1	18 Years -	National Cancer Institute (NCI)
Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer	NCT00060307	Recurrent Renal... Stage III Renal... Stage IV Renal ...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs	NCT03630692	Metastatic Rena... Stage III Renal...	observance of o...	18 Years -	Institut Cancerologie de l'Ouest
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery	NCT01120249	Kidney Cancer	everolimus placebo	18 Years - 120 Years	SWOG Cancer Research Network
Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer	NCT00005966	Kidney Cancer	recombinant int... thalidomide	18 Years -	National Cancer Institute (NCI)
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors	NCT01131234	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Solid Neo... Male Breast Car... Recurrent Adult... Recurrent Breas... Recurrent Colon... Recurrent Melan... Recurrent Non-S... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Stage III Pancr... Stage III Renal... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Skin... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Skin... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Skin... Stage IV Breast... Stage IV Non-Sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Skin M... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Gamma-Secretase... Cediranib Malea... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer	NCT00004890	Drug Extravasat... Kidney Cancer	aldesleukin Biomed 101	18 Years -	National Cancer Institute (NCI)
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery	NCT00003604	Kidney Cancer	aldesleukin	-	National Cancer Institute (NCI)
Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer	NCT00324870	Clear Cell Rena... Recurrent Renal... Stage III Renal... Stage IV Renal ...	vorinostat bevacizumab	18 Years -	National Cancer Institute (NCI)
MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer	NCT00873236	Kidney Cancer	bevacizumab recombinant int...	18 Years -	National Cancer Institute (NCI)
Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer	NCT00354250	Recurrent Renal... Stage III Renal... Stage IV Renal ...	ispinesib	-	National Cancer Institute (NCI)
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma	NCT03229278	Lymphoma Metastatic Mali... Metastatic Mela... Metastatic Rena... Recurrent Bladd... Recurrent Class... Recurrent Head ... Recurrent Lymph... Recurrent Malig... Recurrent Renal... Stage III Bladd... Stage III Lymph... Stage III Non-S... Stage III Renal... Stage III Skin ... Stage IIIA Non-... Stage IIIA Skin... Stage IIIB Non-... Stage IIIB Skin... Stage IIIC Skin... Stage IV Bladde... Stage IV Lympho... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Bladd... Stage IVB Bladd... Unresectable He... Unresectable So...	Enzyme Inhibito... Laboratory Biom... Nivolumab Pembrolizumab	18 Years -	Rutgers, The State University of New Jersey
MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer	NCT00873236	Kidney Cancer	bevacizumab recombinant int...	18 Years -	National Cancer Institute (NCI)
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer	NCT00908739	Kidney Cancer	gene expression... immunohistochem... laboratory biom...	-	Case Comprehensive Cancer Center
Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery	NCT00459979	Kidney Cancer	sunitinib malat... conventional su...	18 Years -	Case Comprehensive Cancer Center
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer	NCT00403169	Kidney Cancer	lenalidomide	18 Years - 120 Years	The Cleveland Clinic
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer	NCT00096525	Kidney Cancer	lenalidomide	18 Years -	Memorial Sloan Kettering Cancer Center
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors	NCT00089362	Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas...	alvespimycin hy... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Gene Therapy in Treating Patients With Cancer	NCT00004178	Cancer	therapeutic aut...	18 Years -	Roger Williams Medical Center
Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer	NCT00004890	Drug Extravasat... Kidney Cancer	aldesleukin Biomed 101	18 Years -	National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer	NCT00004065	Bladder Cancer Breast Cancer Colorectal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Lung Cancer Melanoma (Skin) Ovarian Cancer Prostate Cancer Unspecified Adu...	tanespimycin	18 Years -	Memorial Sloan Kettering Cancer Center
Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer	NCT00003551	Kidney Cancer	aminocamptothec...	18 Years -	National Cancer Institute (NCI)
Lymphocyte Therapy in Treating Patients With Kidney Cancer	NCT00002589	Kidney Cancer	aldesleukin muromonab-CD3 therapeutic aut... adjuvant therap...	16 Years -	National Cancer Institute (NCI)
Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer	NCT00684996	Recurrent Renal... Renal Cell Carc... Stage III Renal... Stage IV Renal ...	etaracizumab bevacizumab	-	National Cancer Institute (NCI)
S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer	NCT00311545	Kidney Cancer	CNTO 328	18 Years -	SWOG Cancer Research Network
Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer	NCT00354250	Recurrent Renal... Stage III Renal... Stage IV Renal ...	ispinesib	-	National Cancer Institute (NCI)
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery	NCT00003604	Kidney Cancer	aldesleukin	-	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: